WT
FPRX

Whittier Trust’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Whittier Trust’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-290
Closed -$1K – 1654
2019
Q3 		$1K Hold
290
– – ﹤0.01% 1534
2019
Q2 		$2K Hold
290
– – ﹤0.01% 1253
2019
Q1 		$4K Hold
290
– – ﹤0.01% 1163
2018
Q4 		$3K Hold
290
– – ﹤0.01% 1223
2018
Q3 		$4K Hold
290
– – ﹤0.01% 1147
2018
Q2 		$5K Buy
+290
New +$5.06K ﹤0.01% 1109

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Whittier Trust's FPRX Position: Q4 2019 in Review

Whittier Trust sold out of Five Prime Therapeutics, Inc. (FPRX) in Q4 2019, closing a stake of 290 shares — an estimated $1K sold.

Whittier Trust first reported a position in FPRX in Q2 2018 and held it in 6 quarters. The position peaked at $5K in Q2 2018. 94 funds tracked by Wall St. Rank hold FPRX as of Q4 2019.

  • Whittier Trust reported no remaining Five Prime Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
  • Whittier Trust sold 290 Five Prime Therapeutics, Inc. shares in Q4 2019, an estimated $1K.
  • Whittier Trust first reported a position in Five Prime Therapeutics, Inc. in Q2 2018 and held it in 6 quarters.
  • Whittier Trust's Five Prime Therapeutics, Inc. position peaked at $5K in Q2 2018.
  • 94 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2019.

Based on Whittier Trust's 13F filing for Q4 2019, filed 31 Jan 2020.